相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
BRCA mutated pancreatic cancer: A change is coming
Michael N. Rosen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2021)
Breast Cancer, Version 3.2020
William J. Gradishar et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)
An assessment of poly (ADP-ribose) polymerase-1 role in normal and cancer cells
Manoj Kumar et al.
BIOFACTORS (2020)
Poly(ADP-ribose) polymerase inhibition: past, present and future
Nicola J. Curtin et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Epithelial ovarian cancer
Stephanie Lheureux et al.
LANCET (2019)
Evaluation of the contribution of germline variants in BRCA1 and BRCA2 to uveal and cutaneous melanoma
Peter A. Johansson et al.
MELANOMA RESEARCH (2019)
Germline BRCA mutation in male carriers-ripe for precision oncology?
Ricardo Romao Nazario Leao et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2018)
Thyroid cancer: trends in incidence, mortality and clinical-pathological patterns in Zhejiang Province, Southeast China
Lingbin Du et al.
BMC CANCER (2018)
Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study
Anas M. Saad et al.
BMC CANCER (2018)
Main steps in DNA double-strand break repair: an introduction to homologous recombination and related processes
Lepakshi Ranjha et al.
CHROMOSOMA (2018)
Germline DNA-repair Gene Mutations and Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Receiving First-line Abiraterone and Enzalutamide
Emmanuel S. Antonarakis et al.
EUROPEAN UROLOGY (2018)
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
K. Moore et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
Karoline B. Kuchenbaecker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Synthetic lethality and cancer
Nigel J. O'Neil et al.
NATURE REVIEWS GENETICS (2017)
A Novel Use of Olaparib for the Treatment of Metastatic Castration-Recurrent Prostate Cancer
Grace A. Martin et al.
PHARMACOTHERAPY (2017)
Breast cancer risk in Chinese women with BRCA1 or BRCA2 mutations
Lu Yao et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Effect of BRCA germline mutations on breast cancer prognosis: A systematic review and meta-analysis
Zora Baretta et al.
MEDICINE (2016)
The prevalence and spectrum of BRCA1 and BRCA2 mutations in Korean population: recent update of the Korean Hereditary Breast Cancer (KOHBRA) study
Eunyoung Kang et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study
Elizabeth K. Bancroft et al.
EUROPEAN UROLOGY (2014)
Novel and recurrent BRCA1/BRCA2 mutations in early onset and familial breast and ovarian cancer detected in the Program of Genetic Counseling in Cancer of Valencian Community (eastern Spain). Relationship of family phenotypes with mutation prevalence
Inmaculada de Juan Jimenez et al.
FAMILIAL CANCER (2013)
Germline BRCA Mutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer
Elena Castro et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Double heterozygosity for mutations in BRCA1 and BRCA2 in German breast cancer patients: implications on test strategies and clinical management
Simone Heidemann et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer
Kelly L. Bolton et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Strategies for the Use of Poly(adenosine diphosphate ribose) Polymerase (PARP) Inhibitors in Cancer Therapy
Cecilia E. Stroem et al.
BIOMOLECULES (2012)
Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients
P. M. L. H. Vencken et al.
ANNALS OF ONCOLOGY (2011)
The prevalence of BRCA2 mutations in familial pancreatic cancer
Fergus J. Couch et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
BRCA2: breaks, mistakes and failed separations
TM Rudkin et al.
TRENDS IN MOLECULAR MEDICINE (2005)
The BRCA2 homologue Brh2 nucleates RAD51 filament formation at a dsDNA-ssDNA junction
HJ Yang et al.
NATURE (2005)
Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2
MJ Daniels et al.
SCIENCE (2004)
Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2 -: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial
MC King et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
分享论文
